Bioactive Milk Peptides and Blood Pressure

NCT01031485 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2014-12-23

No results posted yet for this study

Summary

The purpose of this study is to investigate the effects of bioactive milk peptides on blood pressure in mildly hypertensive subjects.

Conditions

  • Stage 1 Hypertension

Interventions

DIETARY_SUPPLEMENT

Milk peptides and plant sterols

OTHER

Placebo

Sponsors & Collaborators

  • University of Helsinki

    collaborator OTHER
  • Valio Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-06-30
Completion
2010-08-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01031485 on ClinicalTrials.gov